Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
136.79+4.77 (+3.61%)
At close: 04:00PM EDT
137.00 +0.21 (+0.15%)
After hours: 05:19PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • C
    Cesar
    Nothing wrong with this stock at these prices. It is a quality growth company so far.
    Bullish
  • P
    Paul
    Shocked at this price action….. such a good, well-managed company from my research. Am I missing something here?
  • S
    Stockguru
    4.7 yield now. Wow!!
  • S
    Stockguru
    Added more at $138.90
  • R
    R
    Why is this stock sinking so much? The fundamentals are strong. I bought in at $157 and now down considerably. Thoughts please.
  • S
    Stockguru
    From the company…

    We are steadfast in our efforts to drive stockholder value. $MED recently announced a $100 million accelerated share repurchase program, highlighting our confidence in Medifast’s long-term potential.
  • R
    Ricardo
    Just keep buying
  • S
    Stockguru
    Be nice if we can close over $137 today and $140 next week..
  • M
    Mike Scar
    Opened a position at $140.
  • C
    Craig
    Yeah a Green Day. I will take it lol
  • S
    Stockguru
    Added after hours at $161. Nothing wrong with that report.
  • b
    bill
    $129.88 order is confirmed on 8/9 love this value.
    Bullish
  • w
    whodidntante
    Beat top and bottom line... again... Any price decline from here puts the dividend on the radar of income investors (if it wasn't already due to the dividend growth)...
  • b
    bill
    Buying more shares under $145 was a gift. I am grateful for this opportunity to increase my holding on 8/4. I am a user of the OptaVIA product and it helped me lose 45 pounds in 2019 and 3 years later I have not gained it back. I am 56 now and I feel that this company and how I feel minus the pounds will add years to my life and I will spending my MED shares when I am 70+.
    Bullish
  • S
    Stockguru
    Director buys 8280 shares. Nice positive. CEO has to be buying as well. He just bought in May at $183.25. So you would think he’s buying as well here.
  • P
    Paul
    Fundamentals are still excellent. Management team is strong and trustworthy. Forward guidance is realistic and honest. With such low float, count, and volume this is easily manipulated down. Remember, hedgies live quarter to quarter, not long-term. Great buying opportunity. I added at $148 thinking it was bottom…. Lol. If those goes to $120, I’ll re-mortgage my house lol…
  • S
    Stockguru
    How does a stock go down $28 on less then 40,000 shares traded lol
  • C
    Craig
    So it’s now down $3 pre market after being up $4 just 20 min ago. 200 shares knocks it down $7. Seems shady here. Company needs to cone out and defend the stock. Where’s that big buy back. Shareholder value they say lol. Show us then. I’m in at $168 and that’s after buying lower 4 times.
  • B
    Beth
    revenue greater than market cap. never seen that before.
  • S
    Stockguru
    We delivered another solid quarter at Medifast, with revenues up 15%, almost 15% growth in the number of active earning Coaches, and robust Coach productivity. The customized support of OPTAVIA Coaches remains a key differentiator for our business, and these results are a demonstration of the continued strength of our model, " said Dan Chard, Chairman and Chief Executive Officer of Medifast. "We're not immune to issues in the wider macroeconomic environment, and like many consumer-focused businesses, we've seen the impact of inflation on customer retention and consumer sentiment, which will cause slower-than-anticipated growth in the second half. However, we believe we remain well positioned for significant future growth as we continue to execute our core strategies and expand further into the broader health and wellness arena.
Advertisement
Advertisement